IgE Antibodies: Structure, Function in Allergy and Parasite Defense

IgE is a paradox. It is by far the rarest antibody in the blood, present at levels tens of thousands of times lower than IgG, yet it triggers the most dramatic and fastest immune reactions the body can produce, from a sudden hives outbreak to life-threatening anaphylaxis within minutes. How can the scarcest antibody cause the biggest reactions? The answer is that IgE does not wait in the blood to be used. It is loaded onto mast cells in advance, like primed traps, so that the tiniest amount of allergen sets off an immediate, explosive response. This article covers IgE's structure, that trap-setting mechanism, and its two opposite faces: harmful in allergy, protective against parasites.

Immunoglobulin E (IgE) is one of five isotypes of human immunoglobulins: IgG, IgA, IgM, IgD, and IgE. IgE is commonly associated with the various manifestations of allergic disease and protection against repeated infestations with helminths. Immunoglobulin E (IgE) antibodies were discovered by Kimishige Ishizaka in 1966-1967 in the serum of patients with certain types of allergies.

Structure

Figure: Structure of Antibodies Isotypes

IgE is built on the standard antibody plan of two heavy and two light chains, covered in the article on immunoglobulin structure. What is distinctive is its epsilon (ε) heavy chain. Like the μ chain of IgM, the ε chain has four constant domains (Cε1 to Cε4) instead of three, and no hinge region. That extra domain makes IgE heavier than IgG, about 190 kDa versus 150 kDa. IgE is a monomer, and it exists both as a secreted antibody and as a membrane-bound B-cell receptor on IgE-switched B cells.

The extra constant domain is not just structural trivia. It is the part that binds the IgE receptor on mast cells, which is central to everything IgE does.

Why the rarest antibody causes the biggest reactions

Most antibodies float in the blood and act when they meet their antigen. IgE works differently, and understanding this one difference explains both its allergy role and its antiparasite role.

IgE does not wait in the blood. As soon as it is made, it binds, by its Fc end, to a receptor called FcεRI on the surface of mast cells and basophils. This receptor binds IgE with extraordinarily high affinity, the strongest of any antibody-receptor pair, which is why IgE stays stuck to these cells for weeks. This is also why IgE's blood half-life is only about 2 to 3 days, but its life on a mast cell is 2 to 3 weeks: most IgE is not in the blood at all, it is pre-loaded onto cells.

So a mast cell coated with IgE is a primed trap. Each IgE is pointing its antigen-binding arms outward, waiting. When an allergen arrives and binds across two adjacent IgE molecules (cross-linking them), it springs the trap: the mast cell instantly degranulates, releasing histamine and other mediators. Because the response uses pre-positioned antibody and pre-loaded cells, it happens within minutes, and it needs only a tiny amount of allergen.

This single mechanism, IgE pre-loaded on mast cells, explains both of IgE's roles. Aimed at a harmless allergen, it causes allergy. Aimed at a parasite, it triggers the same explosive response to attack a worm too big to phagocytose.

Properties

Molecular weight

The molecular weight of IgE is 190 kDa, which is more than the molecular weight of IgA, IgG, and IgD, i.e. 150 kDa (as IgE has one extra domain in a heavy chain). As IgA also exists as a dimer, its molecular weight ranges from 150 kDa to 300 kDa. The molecular of IgM (pentameric form) is 900 kDa.

Normal serum level

Average serum concentration of IgE i very low (0.3 μg/mL) i.e, 100,000-fold lower than for IgG. Its concentration is markedly increased in certain allergic conditions, such as bronchopulmonary aspergillosis, or with parasitic diseases, such as schistosomiasis. Blood serum IgE level in a normal individual is only about 0.019% of the immunoglobulin concentration.

Half-Life

The half-life of IgE in plasma is only about 2 to 3 days, the shortest of any antibody class. But once IgE binds its high-affinity receptor FcεRI on mast cells and basophils, it is held there for 2 to 3 weeks. This is why serum IgE levels are so low while tissue mast cells are richly armed with it. There are two IgE receptors worth knowing: FcεRI, the high-affinity receptor on mast cells and basophils that arms them for allergy, and FcεRII (CD23), a low-affinity receptor on other cells that helps regulate IgE production.

Function

Strong protective capacity against helminthic infestations and harmful effects by triggering allergic responses are two major functions of IgE.

Protection from helminthic infestations

Figure: Role of Immunoglobulin E in Helminthic infestations

IgE is central to defense against parasites, especially helminths (worms). A worm is far too large for a phagocyte to engulf, so the body needs a different strategy: coat the worm with IgE, then bring in cells that can attack it from outside. Eosinophils carry receptors for IgE, so they bind the IgE-coated worm and release toxic granule contents directly onto it, damaging the parasite. This is a form of antibody-directed killing against a target too big to eat. Because serum IgE rises in parasitic infections, a high IgE level can be a clue to parasitic disease, as well as to allergy.

IgE does not activate complement or participate in opsonization so its role in defense against bacterial infections is insignificant.

Type I hypersensitivity

IgE is the antibody behind type I (immediate) hypersensitivity, the reactions responsible for hay fever, allergic asthma, hives, and anaphylaxis. The mechanism is the primed-trap process described above: allergen cross-links IgE on mast cells, which degranulate and release histamine and other mediators, producing allergic symptoms within minutes. The full mechanism of type I hypersensitivity, including the early and late phases and the range of clinical outcomes, is covered in a separate article on type I hypersensitivity.

Figure: IgE plays important role in Type I hypersensitivity reaction

How to remember

IgE = the allergy and worm antibody. Two faces, one mechanism: harmful against allergens, protective against helminths.

The rarest antibody, the biggest reaction. IgE is present in the tiniest amounts, but because it is pre-loaded on mast cells, it triggers the fastest and most dramatic responses.

Primed trap: IgE on the mast cell, waiting. IgE binds FcεRI in advance. Allergen cross-links it, the trap springs, the mast cell degranulates in minutes.

Short in blood, long on the cell. IgE lasts 2 to 3 days in serum but 2 to 3 weeks bound to a mast cell. Most IgE is on cells, not in blood.

Worms are too big to eat, so coat and blast. IgE coats the helminth; eosinophils bind the IgE and release toxic granules onto it. Antibody-directed killing of a target too large to phagocytose.

Two receptors: FcεRI (high, arms mast cells), FcεRII/CD23 (low, regulates).

Key exam facts in one table

Where students get confused

"IgE is rare, so it cannot be very important." The opposite. IgE is the rarest antibody but triggers the most powerful and fastest reactions, because it is pre-loaded onto mast cells rather than waiting in the blood.

"IgE floats in the blood like other antibodies." Mostly no. Most IgE is bound to mast cells and basophils via FcεRI, which is why serum levels are so low. It works from the cell surface, not from the blood.

"IgE directly kills the parasite." Not by itself. IgE coats the parasite; eosinophils then bind the IgE and release toxic granules that damage the worm. IgE is the tag; the eosinophil is the weapon.

"A single IgE binding an allergen triggers the reaction." No. The allergen must cross-link two adjacent IgE molecules on the mast cell. This cross-linking is what springs the trap; one IgE binding alone does not.

"IgE causes allergy and parasite defense by two different mechanisms." No, it is the same mechanism, IgE-armed cells degranulating, aimed at two different targets. A harmless allergen causes allergy; a worm gets attacked. The biology is identical; only the target differs.

References and further readings

1. Abbas AK, Lichtman AH, Pillai S. Cellular and Molecular Immunology. 10th ed. Elsevier; 2022.
2. Punt J, Stranford SA, Jones PP, Owen JA. Kuby Immunology. 8th ed. W.H. Freeman; 2019.
3. Delves PJ, Martin SJ, Burton DR, Roitt IM. Roitt's Essential Immunology. 13th ed. Wiley-Blackwell; 2017.